Search

EHA-SIE joint membership

Save money and time money by becoming a joint member of EHA and the Società Italiana di Ematologia. We've joined forces with the Società Italiana di Ematologia (SIE) to offer a special joint membership deal.

Read more

EHA-SSH joint membership

Save money and time by becoming a joint member of EHA and the Swiss Society of Hematology. We've joined forces with the Swiss Society of Hematology (SSH) to offer a special joint membership deal.

Read more

EuroBloodNet aims for better care for patients with rare blood disorders

ERNs is an initiative of the European Commission and consist of networks of healthcare providers and centers of excellence in Europe aimed at improving quality, safety, and access to highly specialised healthcare.

Read more

First randomized evidence for kinase inhibitor activity in acute myeloid leukemia

Despite the success of tyrosine kinase inhibitors in some forms of leukemias such as chronic myeloid leukemia and acute lymphoblastic leukemia, until now a kinase inhibitor had yet to demonstrate activity in acute myeloid leukemia (AML).

Read more

Deadlines & Announcements

New announcements will be published as soon as new elements for the Congress Sponsor Program for EHA2025 are released.

Read more

Regulatory affairs & scientific relations

EHA’s regulatory work: European Medicines AgencyMost of EHA’s regulatory work entails collaboration with the European Medicines Agency (EMA).

Read more

Guidelines for hematologists

For guidance regarding COVID-19, see FAQ by the EHA SWG on Infections

EHA creates clinical practice guidelines for diagnosis and treatment of hematologic diseases.

Read more